WHO ICTRP trial
MELAVIRDINE MESYLATE: PHARMACOCINETIC, RANDOMIZED COMPARISON, OF PARALLEL GROUPS…
PER-018-98 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-018-98 |
|---|---|
| Public title | MELAVIRDINE MESYLATE: PHARMACOCINETIC, RANDOMIZED COMPARISON, OF PARALLEL GROUPS AND OPEN MARBETE OF SQV + 3TC + AZT + DLV TWO OR THREE DAILY TIMES VS SQV + 3TC + AZT + DLV IN THE TREATMENT OF HIV POSITIVE PATIENTS |
| Scientific title | MELAVIRDINE MESYLATE: PHARMACOCINETIC, RANDOMIZED COMPARISON, OF PARALLEL GROUPS AND OPEN MARBETE OF SQV + 3TC + AZT + DLV TWO OR THREE DAILY TIMES VS SQV + 3TC + AZT + DLV IN THE TREATMENT OF HIV POSITIVE PATIENTS |
| Primary sponsor | PHARMACIA & UPJOHN INTERAMERICAN CORPORATION, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | IV |
| Interventions | Group name:NA Type of group;1 N° of participants:NA Intervention(s) description:NA |
| Registration date | Dec 24, 1998 |
| Target size | 0 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: